!!Fu-Dong Shi - Selected Publications
1. Li J#, Meng X#, __Shi FD__#, Jing J#, Gu HQ, Jin A, Jiang Y, Li H, Johnston SC, Hankey GJ, Easton DJ, Chang L, Shi P,Wang L, Zhuang X, Li H, Zang Y, Zhang J, Sun Z, Liu D, Li Y, Yang H, Zhao J, Yu W, Wang A, Pan Y, Lin J, Xie X, Jin WN, Li S, Niu S, Wang Y, Zhao X, Li Z, Liu L, Zheng H, Wang Y; CHANCE-3 Investigators. Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial. __British Medical Journal__. 2024 Jun 26:385:e079061.  # Co-first author.\\ 
\\
2. Zhang C, __Shi FD__.Targeting B cells in neuromyelitis optica spectrum disorder.__ Lancet Neurology__. 2024,23:549-550.\\
\\
3.Jiang S, Li X, Li Y, Chang Z, Yuan M, Zhang Y, Zhu H, Xiu Y, Cong H, Yin L, Yu ZW, Fan J, He W, Shi K, Tian DC, Zhang J, Verkhratsky A, Jin WN*, __Shi FD__. APOE from patient-derived astrocytic extracellular vesicles alleviates neuromyelitis optica spectrum disorder in a mouse model. __Science Translational Medicine__. 2024;16(736):eadg5116. \\
\\
4. Li Z, Zhang C, Chang T, Zhang X, Yang H, Gao F, Feng J, Liu H, Chen S, Wang L, Yang C, Li H, Pan Y, Palace J, __Shi FD__. A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study. __Lancet Reginal Health West Pacific__. 2023, 38:1-9. \\
\\
5. Shi K, Li H, Chang T, He W, Kong Y, Qi C, Li R, Huang H, Zhu Z, Zheng P, Ruan Z, Zhou J, __Shi FD__, Liu Q. Bone marrow hematopoiesis drives multiple sclerosis progression. __Cell__. 2022;185: 1-14. \\
\\
6. Li Z, Li Y, Han J, Zhu Z, Li M, Liu Q, Wang Y, __Shi FD__. Formyl peptide receptor 1 signaling potentiates inflammatory brain injury. __Science Translational Medicine__. 2021;13(605):eabe9890. \\
\\
7. Zhang C, Zhang M, Qiu W, Zhang X, Ma H, Zhu Z, Yang CS, Jia D, Zhang TX, Yuan M, Feng Y, Yang L, Lu W, Yu C, Bennett J, __Shi FD__. Tocilizumab versus azathioprine in neuromyelitis optica spectrum disorder (TANGO). __Lancet Neurology__. 2020;19: 391-401. \\
\\
8. Liu Q, Jin WN, Liu Y, Shi K, Sun H, Zhang F, Zhang C, Gonzales R, Sheth KN, La Cava A, __Shi FD__. Brain ischemia suppresses immunity in the periphery and brain via different neurogenic innervations. __Immunity__. 2017;46:474-487. \\
\\
9. Fu Y, Liu Q, Anrather J, __Shi FD__. Immune interventions in stroke. __Nature Review Neurology__. 2015;11:524-35. \\
\\
10. Liu Q, Sanai N, Jin WN, La Cava A, Van Kaer L, __Shi FD__. Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation. __Nature Neuroscience__. 2016; 19:243-52. \\
\\
11. Gan Y, Liu Q, Wu W, Yin J, Tang Z, Turner G, Chen J, Wang Y, Lanrent J, Yokayama W, __Shi FD__. Ischemic neurons recruit NK cells that accelerate brain infarction. __Proc Natl Acad Sci USA__. 2014;111:2704-9. \\
\\
12. __Shi FD__, Ljunggren HG, La Cava A, Van Kaer, L. Organ-specific features of NK cells. __Nature Review Immunology__. 2011;11;658-671. \\
\\
13. __Shi FD__, Wang H, Li H, Hong S, Tanihuchi M, Link H, Van Kaer L, Ljunggren HG. Natural killer cells determine the outcome of B cell-mediated autoimmunity. __Nature Immunology__. 2000;1:245-251. \\
\\
Total publications: >250 (can be viewed at: [https://pubmed.ncbi.nlm.nih.gov/?term=shi+fd]). 



























[{ALLOW view All}][{ALLOW edit fshi}][{ALLOW upload fshi}][{ALLOW comment All}]